Clinical Trials on 慢性乙型肝炎(HBeAg 阴性) in Hong Kong
总计216个结果
-
Chinese University of Hong Kong完全的
-
The University of Hong KongResearch Grant Council招聘中
-
Chinese University of Hong Kong撤销
-
The University of Hong KongNovartis Pharmaceuticals完全的
-
Chinese University of Hong KongGlaxoSmithKline; Hoffmann-La Roche完全的
-
Chinese University of Hong KongHoffmann-La Roche完全的
-
The University of Hong KongJanssen, LP未知滤泡性淋巴瘤 | 慢性乙型肝炎 | 慢性淋巴细胞白血病 | 套细胞淋巴瘤 | 淋巴瘤,小淋巴细胞 | 惰性 B 细胞淋巴瘤 | 华氏巨球蛋白血症香港
-
F-star Therapeutics, Inc.PRA Health Sciences终止
-
The University of Hong Kong完全的
-
Humanity and Health Research CentreBeijing 302 Hospital; Nanfang Hospital of Southern Medical University完全的
-
Chinese University of Hong Kong完全的
-
Arrowhead PharmaceuticalsICON Clinical Research终止
-
LG Life Sciences完全的
-
LG Life Sciences未知
-
Chinese University of Hong Kong终止
-
The University of Hong Kong完全的
-
Gilead SciencesF-star Therapeutics, Inc.终止
-
The University of Hong Kong完全的
-
Humanity and Health Research CentreUniversity of Maryland; Emory University; Beijing 302 Hospital撤销
-
GlaxoSmithKlineIonis Pharmaceuticals, Inc.完全的
-
Chinese University of Hong KongUniversity of Malaya终止
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates完全的
-
The University of Hong Kong完全的
-
Humanity and Health Research CentreEmory University; Beijing 302 Hospital完全的
-
Humanity and Health Research CentreBeijing 302 Hospital完全的
-
Humanity and Health Research CentreBeijing 302 Hospital完全的
-
Gilead Sciences完全的HBeAg 阴性慢性乙型肝炎香港, 美国, 英国, 加拿大, 澳大利亚, 西班牙, 台湾, 印度, 日本, 波兰, 罗马尼亚, 俄罗斯联邦, 大韩民国, 意大利, 新西兰, 法国, 火鸡